TECTONIC THERAPEUTIC INC (TECX) Stock News

NASDAQ:TECX - US8789721086 - Common Stock

16.8 USD

-0.47 (-2.72%)

Last: 9/5/2025, 8:00:01 PM

16.9 USD

+0.1 (+0.6%)

After Hours: 9/5/2025, 8:00:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

TECX Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: Chartmill - Mentions: CYTK UTHR IONS PPBT ...

News Image

Here are the top movers in Tuesday's session.

4 days ago - By: Chartmill - Mentions: CYTK UTHR ASNS PPBT ...

News Image

Top movers analysis in the middle of the day on 2025-09-02: top gainers and losers in today's session.

4 days ago - By: Benzinga - Mentions: CYTK UTHR CGC ALTS ...

12 Health Care Stocks Moving In Tuesday's Intraday Session

4 days ago - By: Chartmill - Mentions: CYTK MNKD UTHR IONS ...

News Image

There are notable gap-ups and gap-downs in today's session.

4 days ago - By: Chartmill - Mentions: CYTK MNKD UTHR MOVE ...

News Image

Tuesday's pre-market session: top gainers and losers

4 days ago - By: Benzinga - Mentions: IVA CYTK MNKD UTHR ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

9 days ago - By: Tectonic Therapeutic

Tectonic Therapeutic to Participate in September Investor Conferences

9 days ago - By: Tectonic Therapeutic

Tectonic Therapeutic to Participate in September Investor Conferences

a month ago - By: The Motley Fool

Tectonic (TECX) Q2 R&D Soars 142%

a month ago - By: Tectonic Therapeutic

Tectonic Therapeutic Announces Second Quarter 2025 Financial Results and Recent Business Highlights

a month ago - By: Tectonic Therapeutic

Tectonic Therapeutic Announces Second Quarter 2025 Financial Results and Recent Business Highlights

2 months ago - By: Tectonic Therapeutic

Tectonic Therapeutic Joins Russell 3000® Index

2 months ago - By: Tectonic Therapeutic

Tectonic Therapeutic Joins Russell 3000® Index

4 months ago - By: Tectonic Therapeutic

Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure 2025

4 months ago - By: Tectonic Therapeutic

Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure 2025

4 months ago - By: Zacks Investment Research

Wall Street Analysts See a 258.52% Upside in Tectonic Therapeutic, Inc. (TECX): Can the Stock Really Move This High?

4 months ago - By: Tectonic Therapeutic

Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights

4 months ago - By: Tectonic Therapeutic

Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights

4 months ago - By: Tectonic Therapeutic

Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference

5 months ago - By: Tectonic Therapeutic

Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025

6 months ago - By: Tectonic Therapeutic

Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

6 months ago - By: Tectonic Therapeutic

Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

7 months ago - By: Tectonic Therapeutic

Tectonic Therapeutic to Participate in March Investor Conferences

7 months ago - By: Tectonic Therapeutic

Tectonic Announces $185 Million Private Placement

7 months ago - By: Tectonic Therapeutic

Tectonic Announces $185 Million Private Placement

7 months ago - By: Tectonic Therapeutic

Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF